Banner for leaf pages 2

Eptifibatide (Integrilin)

Also known as Integrilin

Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed eptifibatide to treat sharp chest pain, heart attack, shortness of breath, and angina.

What drug interactions are known?

Do not take eptifibatide if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...